Skip to main content
Krystal Biotech, Inc. logo

Krystal Biotech, Inc. — Investor Relations & Filings

Ticker · KRYS ISIN · US5011471027 LEI · 549300YONUY68210OE41 US Manufacturing
Filings indexed 465 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country US United States of America
Listing US KRYS

About Krystal Biotech, Inc.

https://www.krystalbio.com/

Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, and commercializes genetic medicines for severe, life-threatening, or rare diseases with high unmet medical needs. The company utilizes a proprietary, redosable gene therapy platform to deliver transformative treatments. Krystal has an FDA-approved product and maintains a robust pipeline of drug candidates across several therapeutic areas, including dermatology, respiratory, oncology, ophthalmology, and aesthetics.

Recent filings

Filing Released Lang Actions
8-K - Krystal Biotech, Inc. (0001711279) (Filer)
Regulatory Filings
2026-05-04 English
10-Q - Krystal Biotech, Inc. (0001711279) (Filer)
Interim / Quarterly Report
2026-05-04 English
ARS - Krystal Biotech, Inc. (0001711279) (Filer)
Annual Report FY 2025
2026-04-03 English
DEF 14A - Krystal Biotech, Inc. (0001711279) (Filer)
Proxy Solicitation & Information Statement
2026-04-03 English
SCHEDULE 13G/A - Krystal Biotech, Inc. (0001711279) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - KRYSTAL BIOTECH, INC. (0001711279) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.